Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Chief Legal Officer | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,607,371 |
Reported balance
After 2026-09-15 transaction · row 1
1 source rowRow 1 · 2026-09-15 · Sale · Disposed 6,846 · Balance 1,607,371 F1: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting of 6.25% of restricted stock units originally granted to the Reporting Person on September 15, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting of 6.25% of restricted stock units originally granted to the Reporting Person on September 15, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 00:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 6,846 | $4.78 | $32,723.88 |
DisclosureSEC source: 0001999086-26-000031 · wk-form4_1789517478.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,607,371 F1 · shares: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting of 6.25% of restricted stock units originally granted to the Reporting Person on September 15, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 20:23 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 108,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001999086-26-000023 · wk-form4_1786652630.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,614,217 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030. Read SEC document |
| July 20, 2026 Filed Jul 20, 2026 21:48 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 51,700 | $4.51 | $233,167.00 |
DisclosureSEC source: 0001999086-26-000021 · wk-form4_1784584133.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,505,522 F1 · shares: The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 13, 2026. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:44 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 10,519 | $4.67 | $49,123.73 |
DisclosureSEC source: 0001801170-26-000175 · wk-form4_1784234686.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,557,222 F1 · shares: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 12:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 4,681 | $4.61 | $21,579.41 |
DisclosureSEC source: 0001801170-26-000151 · wk-form4_1781612213.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,567,741 F1 · kind: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:25 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 10,161 | $2.04 | $20,728.44 |
DisclosureSEC source: 0001999086-26-000012 · wk-form4_1776385505.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,572,422 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:20 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 382,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001999086-26-000011 · wk-form4_1775247653.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,582,583 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:30 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 4,528 | $1.98 | $8,965.44 |
DisclosureSEC source: 0001999086-26-000007 · wk-form4_1773779451.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200,061 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:00 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,090 | $2.02 | $12,301.80 |
DisclosureSEC source: 0001999086-26-000005 · wk-form4_1771452005.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,204,589 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 23:05 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 11,686 | $2.81 | $32,837.66 |
DisclosureSEC source: 0001801170-26-000026 · wk-form4_1768950312.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,210,679 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 21:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,404 | $2.70 | $17,290.80 |
DisclosureSEC source: 0001999086-25-000017 · wk-form4_1765919350.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,222,365 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:08 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 7,459 | $2.47 | $18,423.73 |
DisclosureSEC source: 0001999086-25-000015 · wk-form4_1763500103.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,228,769 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 22:30 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 38,086 | $3.53 | $134,443.58 |
DisclosureSEC source: 0001999086-25-000011 · wk-form4_1762295424.xml · nonDerivative · entry 2 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,236,228 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2023. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 22:30 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 131,521 | $3.53 | $464,269.13 |
DisclosureSEC source: 0001999086-25-000011 · wk-form4_1762295424.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,274,314 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:40 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 57,249 | $2.80 | $160,297.20 |
DisclosureSEC source: 0001999086-25-000007 · wk-form4_1760733649.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,405,835 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 23:32 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,403 | $3.14 | $20,105.42 |
DisclosureSEC source: 0001801170-25-000231 · wk-form4_1758151921.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,463,084 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 21:31 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 7,459 | $2.57 | $19,169.63 |
DisclosureSEC source: 0001801170-25-000223 · wk-form4_1755552710.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,469,487 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:07 UTC Amendment | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 38,086 | $2.89 | $110,068.54 |
DisclosureSEC source: 0001801170-25-000187 · wk-form4a_1754341623.xml · nonDerivative · entry 2 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,476,946 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. F3 · balance_after: Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 31, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 21:29 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,404 | $2.89 | $18,507.56 |
DisclosureSEC source: 0001801170-25-000160 · wk-form4_1750195770.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,256,032 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| May 14, 2025 Filed May 15, 2025 20:14 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,345 | $3.31 | $17,691.95 |
DisclosureSEC source: 0001801170-25-000143 · wk-form4_1747340090.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,262,436 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:37 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 27,293 | $3.40 | $92,796.20 |
DisclosureSEC source: 0001801170-25-000116 · wk-form4_1746218239.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,267,781 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:58 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 4,589 | $3.66 | $16,795.74 |
DisclosureSEC source: 0001801170-25-000074 · wk-form4_1742331497.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,295,074 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:59 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 52,500 | $3.80 | $199,500.00 |
DisclosureSEC source: 0001801170-25-000064 · wk-form4_1741388350.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,299,663 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:49 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,345 | $4.46 | $23,838.70 |
DisclosureSEC source: 0001801170-25-000043 · wk-form4_1740001752.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,352,163 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:19 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 28,553 | $4.39 | $125,347.67 |
DisclosureSEC source: 0001801170-25-000039 · wk-form4_1738703965.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,357,508 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 4,308 | $3.60 | $15,508.80 |
DisclosureSEC source: 0001801170-25-000025 · wk-form4_1736543473.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386,061 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of the final 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on June 15, 2021. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 21:18 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,391 | $3.11 | $19,876.01 |
DisclosureSEC source: 0001801170-24-000251 · wk-form4_1734470327.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,390,369 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 7,444 | $3.08 | $22,927.52 |
DisclosureSEC source: 0001801170-24-000238 · wk-form4_1731964288.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,396,760 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 23:37 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 152,040 | $4.12 | $626,404.80 |
DisclosureSEC source: 0001801170-24-000229 · wk-form4_1730763421.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404,204 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:17 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 450,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000215 · wk-form4_1729196226.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,556,244 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 20:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Disposition to issuerClass A Common Stock | 6,391 | $2.99 | $19,109.09 |
DisclosureSEC source: 0001801170-24-000191 · wk-form4_1726603636.xml · nonDerivative · entry 3 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,105,289 F3 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 15, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Disposition to issuerClass A Common Stock | 117,340 | $2.99 | $350,846.60 |
DisclosureSEC source: 0001801170-24-000191 · wk-form4_1726603636.xml · nonDerivative · entry 2 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,111,680 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/2 of the number of earned performance-based restricted stock units, as described above. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 259,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000191 · wk-form4_1726603636.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,229,020 F1 · shares: Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. Read SEC document |
| September 13, 2024 Filed Aug 4, 2025 21:07 UTC Amendment | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 518,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000187 · wk-form4a_1754341623.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,515,032 F1 · shares: Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed to reflect the full number of RSUs that were achieved. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:14 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,241 | $2.51 | $13,154.91 |
DisclosureSEC source: 0001801170-24-000174 · wk-form4_1723839279.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 970,020 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 21:00 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 4,499 | $1.09 | $4,903.91 |
DisclosureSEC source: 0001801170-24-000130 · wk-form4_1718744399.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 975,261 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,241 | $1.02 | $5,345.82 |
DisclosureSEC source: 0001801170-24-000111 · wk-form4_1715891617.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 979,760 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,168 | $0.80 | $4,134.40 |
DisclosureSEC source: 0001801170-24-000074 · wk-form4_1710879069.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 985,001 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| February 14, 2024 Filed Feb 15, 2024 21:41 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,020 | $0.95 | $5,719.00 |
DisclosureSEC source: 0001801170-24-000059 · wk-form4_1708033245.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 990,169 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 21:03 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 3,862 | $0.95 | $3,668.90 |
DisclosureSEC source: 0001801170-24-000038 · wk-form4_1704834204.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 996,189 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on June 15, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:57 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 4,361 | $0.99 | $4,317.39 |
DisclosureSEC source: 0001801170-23-000121 · wk-form4_1703023051.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,051 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:42 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,079 | $1.01 | $5,129.79 |
DisclosureSEC source: 0001801170-23-000111 · wk-form4_1700170939.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,004,412 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 20:38 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-23-000088 · wk-form4_1698957522.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,009,491 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.